Intellia Therapeutics, Inc. Common Stock

Updates from The Motley Fool

Latest updates on Intellia Therapeutics from
3 Stocks That Could Make You Rich

Game-changing innovations make NVIDIA, Ambarella, and Intellia Therapeutics great picks now for p...

Stock Performance

View Interactive NTLA Charts
Sponsored by

Key Data Points

Primary metrics and data points about Intellia Therapeutics.
Current Price: $25.75
Prev Close: $25.84
Open: $25.74
Bid: $25.31
Ask: $26.09
Day's Range: $25.11 - $26.04
52wk Range: $11.15 - $35.99
Volume: 484,956
Avg Vol 805,778
Market Cap: $929M
P/E (ttm): -12.73
EPS (ttm): ($2.03)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Intellia Therapeutics.
CAPS Rating 5 out of 5
41 Outperform
0 Underperform
CAPS All Stars
16 Outperform
0 Underperform

How do you think Intellia Therapeutics will perform against the market?

You pick for Intellia Therapeutics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Nessan Bermingham, Ph.D., CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Intellia Therapeutics.

Intellia Therapeutics, Inc. Common Stock

  • Exchange: NASDAQ